Roivant Sciences Ltd. — Director's Dealing 2026

Feb 24, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Roivant Sciences Ltd. (ROIV)
CIK: 0001635088
Period of Report: 2026-02-19

Reporting Person: Torti Frank (President and Vant Chair)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2026-02-19	Common Shares	M	1400000	$3.85	Acquired	15136547	Direct
2026-02-19	Common Shares	S	1400000	$27.42	Disposed	13736547	Direct
2026-02-20	Common Shares	M	1012610	$3.85	Acquired	14749157	Direct
2026-02-20	Common Shares	S	1012610	$27.15	Disposed	13736547	Direct
2026-02-23	Common Shares	M	587390	$3.85	Acquired	14323937	Direct
2026-02-23	Common Shares	S	587390	$27.51	Disposed	13736547	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2026-02-19	Stock Option (Right to Buy)	$3.85	M	1400000	Disposed	2032-04-19	Common Shares (1400000)	Direct
2026-02-20	Stock Option (Right to Buy)	$3.85	M	1012610	Disposed	2032-04-19	Common Shares (1012610)	Direct
2026-02-23	Stock Option (Right to Buy)	$3.85	M	587390	Disposed	2032-04-19	Common Shares (587390)	Direct

Footnotes

F1: The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.

F2: These Common Shares were sold in multiple transactions at prices ranging from $27.00 to $27.64, inclusive.

F3: These Common Shares were sold in multiple transactions at prices ranging from $26.70 to $27.45, inclusive.

F4: These Common Shares were sold in multiple transactions at prices ranging from $27.14 to $27.80, inclusive.

F5: Reflects an award of stock options to purchase Common Shares with a vesting commencement date of April 20, 2022. These options vest and become exercisable (i) 25% on the first anniversary of the vesting commencement date and (ii) in 36 equal monthly installments thereafter, subject to the reporting person's continuous service through each vesting date (except as otherwise provided in the award documentation).